“…Even if none of the above-described findings is neither sufficient nor necessary for definitive diagnosis, the association of well-defined lesion, highly and inhomogeneously enhancing, with pseudocystic areas, and medium-high signal intensity in MRI-T2 and diffusion weighted-not resembling hemangioma or pseudotumor, could suggest radiologists a diagnosis of intrasplenic extramedullary hemopoiesis [4,5] and then clinicians to perform tests for hematological disorders including myeloproliferative neoplasms, such as bone marrow biopsy, JAK2V617F of MPL mutations in addition to CBC, before referring the patient for splenectomy which can bring some risks of complications.…”